The most potent TNF-α–specific inhibitors (TNFIs) approved by the food and drug administration are biologic drugs, which are used for treatment of peripheral inflammatory conditions, including rheumatoid arthritis, Crohn disease, and psoriasis. Here, TNF is linked to rheumatoid arthritis.